Brief: Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025
Q32 Bio Inc QTTB.O :
* Q32 BIO INC: RESTRUCTURING PLAN INCLUDES REDUCTION IN
FORCE,
WHICH CO EXPECTS TO SUBSTANTIALLY COMPLETE BY END OF Q2 OF 2025
* Q32 BIO INC: EXPECTS TO INCUR SEVERANCE AND
SEVERANCE-RELATED
CHARGES OF ABOUT $1.1 MILLION
Source text: ID:n0000950170-25-017075
Further company coverage: QTTB.O
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview